31 results
Thumbnail

D2.230 - Flushing in a Child with Solitary Cutaneous Mastocytoma: A Case Associated with Sesame Allergy

Thumbnail

D2.231 - Psychological Profiles and Personality Traits in Chronic Spontaneous Urticaria: A Pilot Study

Thumbnail

D2.232 - Aquagenic Urticaria: High Atopic Comorbidity, Familial Aggregation, and Differential Water Reactivity

Thumbnail

D2.233 - Epidemiology, Patient Characteristics, and Treatment Responses of Chronic Urticaria in Türkiye: A Systematic Literature Review

Thumbnail

D2.237 - Patient-reported changes in urticaria activity after tattoo placement

Thumbnail

D2.238 - Bilastine fast onset and strong peripheral antihistaminic activity: comparison with oral second-generation antihistamines and intramuscular dexchlorpheniramine in histamine-induced wheal and flare models

Thumbnail

D2.239 - Oral and parenteral bilastine, fast onset and strong peripheral antihistaminic activity: comparison with oral second-generation antihistamines and intramuscular dexchlorpheniramine in wheal and flare models

Thumbnail

D2.241 - Successful Slow Desensitization to Niraparib Following Failed Olaparib Desensitization in a Patient with Ovarian Cancer

Thumbnail

D2.242 - Chronic Urticaria and Thyroid Disease: Analysis of Clinical, Laboratory Data and Therapeutic Response in the Mediterranean Area of Tarragona

Thumbnail

D2.243 - Impact of simultaneous skin clearance and itch relief with lebrikizumab in patients with atopic dermatitis: post-hoc analysis from ADvocate1/2

Thumbnail

D2.244 - Case Report: Postpartum Chronic Spontaneus Urticaria

Thumbnail

D2.229 - Food Allergy in Ukrainian Children: Risk Factors, Early Allergen Introduction and Natural History

Thumbnail

D2.234 - Mimicry of delayed pressure urticaria. Clinical case reports

Thumbnail

D2.235 - Urticaria Voices: Patient-reported disease burden and treatment experiences in Chronic Spontaneous Urticaria in China - A real-world evidence study (UV in China)

Thumbnail

D2.236 - Alexithymia and Depression in Patients with Chronic Spontaneous Urticaria Treated with Omalizumab

Thumbnail

D2.490 - Consistent efficacy of a seasonal 300IR birch pollen sublingual immunotherapy in children and adolescents during worst pollen exposure: results of the YOBI trial

Thumbnail

D2.491 - Efficacy of a 300IR birch liquid sublingual immunotherapy during the alder and hazel pollen seasons: results of the YOBI trial

Thumbnail

D2.492 - Efficacy and safety of a 300IR daily dose of a SLIT of birch pollen allergen extract in children and adolescents with allergic rhinoconjunctivitis: results from the YOBI trial

Thumbnail

D2.494 - Tralokinumab treatment in adults with atopic dermatitis who were previously treated with dupilumab: 12-months real-world data from the TRACE study

Thumbnail

D2.495 - Treatment with Izicopan (INF904), an oral anti-C5aR inhibitor improves efficacy and safety in patients with chronic spontaneous urticaria: results from a Phase 2a study